These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20809107)

  • 1. Difference in the effects of tandospirone on ataxia in various types of spinocerebellar degeneration: an open-label study.
    Takei A; Hamada S; Homma S; Hamada K; Tashiro K; Hamada T
    Cerebellum; 2010 Dec; 9(4):567-70. PubMed ID: 20809107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tandospirone on "5-HT1A receptor-associated symptoms" in patients with Machado-Josephe disease: an open-label study.
    Takei A; Fukazawa T; Hamada T; Sohma H; Yabe I; Sasaki H; Tashiro K
    Clin Neuropharmacol; 2004; 27(1):9-13. PubMed ID: 15090930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of SCA1, DRPLA, MJD, SCA2, and SCA6 CAG repeats in 48 Portuguese ataxia families.
    Silveira I; Coutinho P; Maciel P; Gaspar C; Hayes S; Dias A; Guimarães J; Loureiro L; Sequeiros J; Rouleau GA
    Am J Med Genet; 1998 Mar; 81(2):134-8. PubMed ID: 9613852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Drug holiday' effects of tandospirone in a patient with Machado-Joseph disease.
    Takei A; Fukazawa T; Hamada T; Yabe I; Tashiro K
    Psychiatry Clin Neurosci; 2003 Dec; 57(6):607-8. PubMed ID: 14629711
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy.
    Lirng JF; Wang PS; Chen HC; Soong BW; Guo WY; Wu HM; Chang CY
    PLoS One; 2012; 7(10):e47925. PubMed ID: 23118909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of the efficacy and safety of tandospirone versus sertraline monotherapy for social anxiety disorder: a randomized open-label trial.
    Huang X; Li C; Li WH; Luo YL; Wang B; Zhang W; Gan JJ; Ji JL
    Hum Psychopharmacol; 2013 Nov; 28(6):594-9. PubMed ID: 24519693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cerebellar ataxia with 5-HT1A agonist.
    Takei A; Hamada T; Yabe I; Sasaki H
    Cerebellum; 2005; 4(3):211-5. PubMed ID: 16147954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of the different mutations causing spinocerebellar ataxia (SCA1, SCA2, MJD/SCA3 and DRPLA) in a large group of Brazilian patients.
    Lopes-Cendes I; Teive HG; Calcagnotto ME; Da Costa JC; Cardoso F; Viana E; Maciel JA; Radvany J; Arruda WO; Trevisol-Bittencourt PC; Rosa Neto P; Silveira I; Steiner CE; Pinto Júnior W; Santos AS; Correa Neto Y; Werneck LC; Araújo AQ; Carakushansky G; Mello LR; Jardim LB; Rouleau GA
    Arq Neuropsiquiatr; 1997 Sep; 55(3B):519-29. PubMed ID: 9629399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathology of spinocerebellar degeneration: its correlation to the unstable CAG repeat of the affected gene.
    Yagishita S; Inoue M
    Pathol Int; 1997 Jan; 47(1):1-15. PubMed ID: 9051687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of spinocerebellar degenerations in the Hokuriku district in Japan.
    Shibata-Hamaguchi A; Ishida C; Iwasa K; Yamada M
    Neuroepidemiology; 2009; 32(3):176-83. PubMed ID: 19169038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Screening for Spinocerebellar Ataxia Genes in a Japanese Single-Hospital Cohort.
    Sakakibara R; Tateno F; Kishi M; Tsuyusaki Y; Aiba Y; Terada H; Inaoka T; Sawai S; Kuwabara S; Nomura F
    J Mov Disord; 2017 Sep; 10(3):116-122. PubMed ID: 28782341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency analysis of autosomal dominant cerebellar ataxias in Japanese patients and clinical characterization of spinocerebellar ataxia type 6.
    Watanabe H; Tanaka F; Matsumoto M; Doyu M; Ando T; Mitsuma T; Sobue G
    Clin Genet; 1998 Jan; 53(1):13-9. PubMed ID: 9550356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of tandospirone and escitalopram as a symptomatic treatment in Multiple System Atrophy-cerebellar ataxia: An open-label, non-controlled, 4 weeks observational study.
    Quan M; Gao J; Xu S; Guo D; Jia J; Wang W
    J Psychiatr Res; 2023 Dec; 168():133-139. PubMed ID: 37907036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [SCA1, SCA2, MJD/SCA3 (CAG)n mutation detection and analysis in patients with hereditary spinocerebellar ataxia from Chinese families].
    Tang B; Wang D; Xia J
    Zhonghua Yi Xue Za Zhi; 1997 Nov; 77(11):819-22. PubMed ID: 9772474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients.
    Silveira I; Lopes-Cendes I; Kish S; Maciel P; Gaspar C; Coutinho P; Botez MI; Teive H; Arruda W; Steiner CE; Pinto-Júnior W; Maciel JA; Jerin S; Sack G; Andermann E; Sudarsky L; Rosenberg R; MacLeod P; Chitayat D; Babul R; Sequeiros J; Rouleau GA
    Neurology; 1996 Jan; 46(1):214-8. PubMed ID: 8559378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of repeat expansions causing autosomal dominant spinocerebellar ataxias in Hokkaido, the northernmost island of Japan.
    Mizushima K; Shibata Y; Shirai S; Matsushima M; Miyatake S; Iwata I; Yaguchi H; Matsumoto N; Yabe I
    J Hum Genet; 2024 Jan; 69(1):27-31. PubMed ID: 37848721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary open-label study of 5-HT1A partial agonist tandospirone for behavioural and psychological symptoms associated with dementia.
    Sato S; Mizukami K; Asada T
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):281-3. PubMed ID: 16817981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.